Research Foundation News

October 29, 2019

Purdue GMP Center now operates as Parsolex and is expanding capabilities

WEST LAFAYETTE, Ind. – Purdue GMP Center Inc. (PGC) is now operating as Parsolex GMP Center Inc., doing business as Parsolex.

“We believe that a name change is appropriate at this time due to the launch of our capital investment program to evolve our company’s capabilities to serve the pharmaceutical industry,” said Alfonso Chang, CEO of Parsolex. “We are making significant investments in adding experts and professionals to our staff, analytical instrumentation, development technologies, and manufacturing equipment, as well as in renovating our West Lafayette, Indiana, facility so that we can better serve our clients with their evolving needs.”

The name Parsolex was identified and selected by the employees as the best method to describe the company, as it combines the concepts of partnership, solutions and excellence.

“These three words describe what we strive to do perfectly,” Chang said.  “We want to work with our clients, as partners, to find the most optimal and innovative solutions to their challenges in an experience that exudes excellence.”

The company launched in 2004 and started operations in 2005 as The Chao Center for Industrial Pharmacy and Contract Manufacturing as an initiative of the Purdue Research Foundation to support Purdue University. Today, the company’s reach goes beyond Purdue University, as clients now include not only other leading academic institutions but also major hospital systems, startups, virtual companies and large multinational pharmaceutical companies from around the globe.

“While we are proud of the company’s history and its achievements thus far, we are even more excited for the company’s future and opportunities to accomplish much more for our clients,” said Dr. Michael Chao, chairman of Parsolex.  “We initiated our capital investment program with the corporate goal of making Parsolex the organization where clients feel confident their technical and commercial challenges can be solved.”

To learn more about Parsolex and its capabilities, visit www.parsolexinc.com. Parsolex will also be exhibiting Nov. 3-6 at the American Association of Pharmaceutical Scientists PharmSci 360 in San Antonio, Booth 918.

About Parsolex

Parsolex is derived from the words “Partner, Solutions, Excellence” – the foundation of everything we do. Since 2004, our experienced team has been committed to innovation in product and process design, development, current Good Manufacturing Practices (CGMP) manufacturing, and testing of solid oral dosage forms. We strive to achieve the success of all our clients to improve patient lives around the world. Parsolex operates a CGMP facility equipped with state-of-the-art manufacturing and analytical technologies located in West Lafayette, Indiana, USA, that is registered with the U.S. Food and Drug Administration. Parsolex’s technical capabilities include formulation and process development, including first-in-human strategies; clinical trial material manufacturing, scale-up, and technology transfer for a broad range of oral solid dosage forms, including but not limited to tablets, film-coated tablets, and hard gelatin capsules filled with powder, granule, and coated-beads; analytical method development and validation services; ICH stability storage; CGMP warehousing; and CGMP commercial manufacturing. Furthermore, Parsolex offers commercialization and strategic advisory services.  For more information about Parsolex’s capabilities, please contact 765-464-8414.  Learn more at www.parsolexinc.com

Purdue Research Foundation contact: Chris Adam, CLAdam@prf.org

Contact: David A. Engers, PhD, Parsolex, director, client services, 765-464-8414


Research Foundation News

Purdue University, 610 Purdue Mall, West Lafayette, IN 47907, (765) 494-4600

© 2015-22 Purdue University | An equal access/equal opportunity university | Copyright Complaints | Maintained by Office of Strategic Communications

Trouble with this page? Disability-related accessibility issue? Please contact News Service at purduenews@purdue.edu.